Decellularised nucleus pulposus as a potential biologic scaffold for disc tissue engineering.

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Cell Biology

Background:

• Intervertebral disc (IVD) degeneration, a major cause of lower back pain, is initiated by nucleus pulposus (NP) cell dysfunction.
• Developing effective treatments for IVD degeneration remains a significant challenge in regenerative medicine.

Purpose of the Study:

• To develop an optimized decellularized NP scaffold capable of inducing mesenchymal stem cells (MSCs) into NP-like cells.
• To evaluate the therapeutic potential of this scaffold in an in vivo model of IVD degeneration.

Main Methods:

• An optimized decellularization protocol was used for porcine NP tissue to create a scaffold.
• The biological properties and microstructure of the NP scaffold were analyzed.
• MSCs were co-cultured with the scaffold to assess bioactivity and signaling pathways (e.g., TGF-β).
• The scaffold's efficacy was tested in an established in vivo IVD degeneration model.

Main Results:

• The decellularization process effectively removed cellular components while preserving the extracellular matrix (ECM) structure and biological properties.
• MSCs cultured on the NP-ECM scaffold differentiated into NP-like cells, with evidence of TGF-β pathway activation.
• The NP-ECM scaffold demonstrated good cytocompatibility and significantly decelerated IVD degeneration in vivo.

Conclusions:

• A naturally derived ECM material from NP tissue was successfully developed.
• This scaffold can induce MSCs to differentiate into NP-like cells, suggesting a promising cell-based therapy.
• The developed NP-ECM scaffold holds potential as a novel therapeutic strategy for treating degenerated IVDs.